바로가기 메뉴
본문 바로가기
푸터 바로가기
TOP

Early recombinant human epidermal growth factor treatment recovers the irradiation-induced decrease of Na+ absorption prior to the definite histological mucositis

저자

Kim JK, Kim CS, Ahn HJ, Bang SR, Kim SJ, Yoo HY, Jeong HS

저널 정보

Biomedicine and Pharmacotherapy

출간연도

Nov 2010

Recombinant human epidermal growth factor (rhEGF) has potential benefit for the mucositis induced by radiation therapy as a therapeutic setting. In this study, we aimed to investigate the effects of rhEGF treatment on the radiation-induced changes in epithelial transport function, before the occurrence of the definitive histological mucosal changes. C3H/He mice received 0, 4, or 8 Gy irradiation and/or EGF treatment (rhEGF 0, 1 and 5mg/kg, i.p., 5 days). At day 7, we recorded short circuit current (Isc) of the upper tracheal epithelium using the flow-type Ussing chamber method, with histological analysis. As a result, there was no evident pathological change in the epithelium from the irradiated and/or rhEGF treated mice at day 7. The initial level of Isc and amiloride-sensitive Isc (ΔIsc,Amil) were decreased after 8 Gy irradiation, reflecting suppression of basal Na+ absorption. The decreased ΔIsc,Amil was recovered by rhEGF treatment. In conclusion, epithelial Na+ channel-dependent basal Na+ absorption was primarily affected by irradiation, before the pathological changes. The recovery of basal Na+ absorption (ΔIsc,Amil) suggested a potentially beneficial effect of early rhEGF treatment for irradiation-induced suppression of the upper aerodigestive epithelial functions.